Lysosomal Therapeutics

Lysosomal Therapeutics

Delivering cures for neurodegenerative diseases.

Launch date
Employees
Market cap
-
Enterprise valuation
$80—120m (Dealroom.co estimates Feb 2015.)
Cambridge Massachusetts (HQ)
Authorizing premium user...